What Mechanisms Drive Diabetes-Risk in Youth with Pancreatitis?

Dr. Larson Ode
Dr. Catherina Pinnaro

Why does diabetes happen in some children who have experienced pancreatitis? A new study from Dr. Larson Ode and Dr. Pinnaro, along with a former research fellow Dr. Parra Villasmil, delves into this very question, uncovering unexpected patterns. Their work has been just published in the Journal of Pediatric Gastroenterology and Nutrition. The manuscript, titled “Early mechanisms of diabetes development in pediatric pancreatitis – a pilot study”, explores the complex interplay between pancreatitis and diabetes risk in children. Diabetes is a serious complication for children with pancreatitis, affecting nearly 9% during childhood and up to half over a lifetime. Despite this high risk, little is known about the underlying mechanisms or biomarkers that predict which children are most vulnerable. This study takes an important step toward filling that gap. Their findings revealed that 35% of participants exhibited dysglycemia, often linked to insulin resistance. Could insulin resistance be the key mechanism that drives diabetes risk? Another surprise finding was that dysglycemia was associated with higher pancreatic polypeptide levels. These results will help inform future studies that could pave the way for earlier detection and/or targeted interventions to prevent diabetes in this high-risk population. The manuscript is indexed on PubMed at this URL.

Happy Wedding!

Multiple nurses, docs, an emerita, a pharmacist and spouses from our division on the dance floor shortly after the marriage of Haylee and Sam. Cheers to the newlyweds!

Inhaled Insulin Shows Some Benefits for Children with Type 1 Diabetes in Landmark Clinical Trial

Dr. Tansey

We are proud to announce our division’s contribution to a major clinical study recently published in Diabetes Care: “INHALE-1, A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.” One of our Division physicians, Dr. Tansey, served as a co-author on this important research. The INHALE-1 trial examined the safety and effectiveness of an inhaled form of insulin compared to standard rapid-acting insulin injections in 230 children and adolescents aged 4 to 17 living with diabetes. Over a 26-week period, participants continued their long-acting basal insulin and used continuous glucose monitoring while receiving either inhaled or injected rapid acting insulin. Compared to the injected insulin group, the inhaled insulin group experienced a similar hemoglobin A1c, similar continuous glucose monitor readings, and lung function. Children using TI reported greater treatment satisfaction and experienced less weight gain compared to those on injected insulin. These findings suggest that inhaled insulin could become a valuable option for some pediatric patients. It is important to note that the study did not compare inhaled insulin to insulin pump-based therapy. The manuscript abstract is available on Pubmed. We especially wish to thank the research coordinators, research participants and their families who made this study possible.

Celebration of a Rich Journey!

We celebrated the retirement of Rich, endocrinology nurse. We have blessed for over a decade by Rich’s excellence and deep clinical experience, not to mention his collection of weekly humorous memes. Today, we had a luncheon in his honor, complete with anime masks. We wish him a rich journey in retirement.

Anime Masks!
Kitsune selfie

Breakthrough T1D Promise Gala 2025

Multiple division members attended the 2025 fund raising Gala for Breakthrough T1D in Cedar Rapids on November 1st. Breakthrough T1D is the leading non-profit fund raising organization aiming to drive research that finds cures for type 1 diabetes.

At the Gala: Pediatric Diabetes Nurses ready to help with the challenges of T1D!!!

Breakthrough T1D Promise Gala: some of the division attendees and friends!!!

Our Program Ranked Among the Best Children’s Diabetes & Endocrinology Programs Nationally

We are excited to share that our Division has been rated among the Best Children’s Hospitals for Diabetes & Endocrinology Care by the US News 2025-2026 annual national report, where we were ranked #33 nationwide. Other top ranked specialties at the University of Iowa Stead Family Children’s Hospital included neonatology (#19), nephrology, urology, pediatric cancer, and behavioral health.

“Our ongoing strong national ranking is a testament to the steadfast dedication and expertise of our pediatric endocrine physicians, nurse practitioners, specialty nurses, diabetes educators, psychologists, researchers, medical assistants, dieticians, pharmacists, social workers, and all teams members. We remain devoted to provide the best endocrine and diabetes care for the children and adolescents in the region and beyond.”

Andrew Norris, M.D. Ph.D.
Director, Division of Endocrinology and Diabetes
UI Stead Family Children’s Hospital

Lifestyle Counseling for Adolescents by Physicians

Dr. Kanner

Lifestyle interventions can be a very powerful means to impact adolescent obesity. However lifestyle counseling of adolescence is notoriously difficult. Physicians are often poorly trained to meet this challenge. These discussions are fraught with some risk that insensitive approaches might trigger disordered eating and/or disturbed body image. To help physicians address these challenges, Dr. Lauren Kanner from our division is part of a team delivering a lecture entitled “Neither Feast nor Famine: Weight-Inclusive Approaches to Counseling Youth with Higher BMIs”. This lecture aims to provide physicians with strategies to effectively counsel adolescents to enact positive lifestyle changes. The lecture will be delivered by Dr. Kanner in conjunction with Dr. Maya Kumar from Rady Children’s Hospital. The lecture is co-sponsored by Society for Adolescent Health and Medicine (SAHM) and the North American Society for Pediatric & Adolescent Gynecology (NASPAG). The webinar will occur on October 8, 2025. See this link to sign up to view the webinar.

Grand Rounds: Medical and Psychological Care for DSD

Dr. Akhila Ramakrishna

On September 19th, Dr. Ramakrishna from our division co-presented Pediatric Grand Rounds along with pediatric psychologist Dr. Laura Fuller. Their talk, entitled “Treating Patients with Differences of Sexual Development: The Intersection of Medicine and Psychology”, explored the complexities of the medical and psychological healthcare of Differences of Sexual Development (DSD).

DSDs encompass a group of conditions in which the typical processes of sexual development—anatomical, hormonal, functional, and reproductive—do not follow the usual male or female patterns. These variations may be apparent at birth or even prenatally, though some forms may not be diagnosed until adolescence or adulthood.

The primary goal of pediatric DSD care is to support the physical and emotional well-being of affected individuals during youth. During their presentation, Drs. Ramakrishna and Fuller provided an overview of the various types of DSDs and illustrated the unique medical and psychosocial needs of patients through case examples. They emphasized the importance of a multidisciplinary approach to care.

Drs. Ramakrishna and Fuller lead a multidisplinary DSD clinic that includes pediatric endocrinologists, pediatric urologists, clinical geneticists, and pediatric radiologists, with support from reproductive endocrinology and clinical pharmacy services.

We extend our sincere thanks to Drs. Ramakrishna and Fuller for their insightful presentation and for their leadership in delivering expert, compassionate DSD care through their multidisciplinary team.